WuXi PharmaTech (药明康德) reported its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC), an important step in WuXi’s goal of gaining international acceptance of the new lab. The Suzhou lab adds GLP toxicology, drug metabolism and bioanalytical chemistry capabilities to the company’s core drug discovery services, which are conducted in WuXi’s Shanghai facility. More details...

Stock Symbol: (NYSE: WX)